PHILLIP BRIAN SMITH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

PK Study With Pantoprazole in Obese Children and Adolescents

Phase 1
Completed
Conditions
Interventions
First Posted Date
2014-07-10
Last Posted Date
2019-09-17
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
41
Registration Number
NCT02186652
Locations
🇺🇸

University of Arkansas, Little Rock, Arkansas, United States

🇺🇸

Children's Mercy Hospital, Kansas City, Missouri, United States

🇺🇸

East Carolina University, Greenville, North Carolina, United States

and more 1 locations

Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile

Phase 1
Completed
Conditions
Interventions
First Posted Date
2012-12-07
Last Posted Date
2016-11-29
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
22
Registration Number
NCT01744730
Locations
🇺🇸

University of Louisville, Louisville, Kentucky, United States

🇺🇸

Children's Mercy Hospital, Kansas City, Kansas, United States

🇺🇸

Akron Children's Hospital, Akron, Ohio, United States

and more 1 locations

Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2012-11-19
Last Posted Date
2023-07-27
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
63
Registration Number
NCT01728363
Locations
🇺🇸

University of Louisville, Louisville, Kentucky, United States

🇺🇸

Duke University, Durham, North Carolina, United States

🇺🇸

Kings County Hospital Center, Brooklyn, New York, United States

and more 7 locations

Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants

Phase 1
Withdrawn
Conditions
Interventions
First Posted Date
2010-10-27
Last Posted Date
2012-11-14
Lead Sponsor
Phillip Brian Smith
Registration Number
NCT01229046
Locations
🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-07-20
Last Posted Date
2019-01-08
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
32
Registration Number
NCT00942084
Locations
🇺🇸

Tulane School of Medicine, New Orleans, Louisiana, United States

🇺🇸

Wesely Medical Center, Wichita, Kansas, United States

🇺🇸

Duke University, Durham, North Carolina, United States

Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-04-01
Last Posted Date
2018-10-03
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
32
Registration Number
NCT00873327
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

🇺🇸

Indiana University School of Medicine, Indianapolis, Indiana, United States

🇺🇸

Wesley Medical Center, Wichita, Kansas, United States

and more 1 locations

An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-02-24
Last Posted Date
2018-09-04
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
9
Registration Number
NCT00850122
Locations
🇧🇷

Federal University of Sao Paulo, Sao Paulo, Brazil

Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease

First Posted Date
2008-11-17
Last Posted Date
2018-09-04
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
5
Registration Number
NCT00792246
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath